期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

流感病毒耐药机制研究进展 被引量：2

下载PDF
导出
作者 刘娟 秦成峰 秦鄂德
机构地区 军事医学科学院微生物流行病研究所 空军总医院输血科
出处 《解放军医学杂志》 CAS CSCD 北大核心 2010年第8期1029-1031,共3页 Medical Journal of Chinese People's Liberation Army
基金 国家科技重大专项(2009ZX10004-204) 国家重点基础研究发展计划(2010CB534002)
关键词 流感病毒 抗药性 病毒 突变
分类号 R511.7 [医药卫生—内科学]
  • 相关文献

参考文献20

  • 1李卓荣,刘宗英,汤雁波.抗流感病毒药物的研究进展[J].国外医药（抗生素分册）,2002,23(4):151-154. 被引量：9
  • 2Hurt AC, Holien JK, Parker M. Zanamivlr resistant influenza viruses with a novel neuraminidase mutation[J]. J Virol, 2009, 83(20): 10366-10373.
  • 3Sheu TG, Deyde VM, OkomcrAdhiambo M. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008[J]. Antimicrob Agents Chemother, 2008, 52(9): 3284-3292.
  • 4Ives JA, Carr JA, Mendel DB The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo [J].Antiviral Res, 2002, 55(2) : 307- 317.
  • 5Townsend MB, Smagala JA, Dawson ED, etal. Detection of adarnan tane-resistant influenza on a microarray[J]. J Clin Virol, 2008, 42 (2) : 117-123.
  • 6Ferraris O, Kessler N, Lima B. Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice[J]. Antiviral Res, 2005, 68(1): 43-48.
  • 7Baz M, Abed Y, Boivin G. Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir[J].. Antiviral Res, 2007, 74(2): 159-162.
  • 8奥野良信,万献尧,毕丽岩.金刚烷胺[J].日本医学介绍,2004,25(7):307-309. 被引量：20
  • 9Saito R, Sakai T, Sato I, et al. Frequency of amantadineresistant influenza A viruses during two seasons featuring cocirculation of H1N1 and H3N2[J]. J Clin Mierobiol, 2003, 41(5): 2164-2165.
  • 10Hurt AC, Ernest J, Deng YM. Emergence and spread of oseltamivir resistant A (HIN1) influenza viruses in Oceania, South East Asia and South Africa[J]. Antiviral Res, 2009, 83(1) : 90-93.

二级参考文献15

  • 1[1]Stamboulian D,Bonvehi PE. Influenza. [J]. Infect Dis Clin North Am, 2000,14(1) : 141
  • 2[2]Dolin R,Reichman RC,Madore HP,et al. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza infection. [J]. N Engl J Med, 1982,307 : 580
  • 3[3]Markvon IM, Wu W-Y, Kok GB, et al. Rational design of potent sialidase-based inhibitiors of influzena virus replication. [J]. Nature, 1993,363 : 418
  • 4[4]Calfee DP, Hayden FG. New approaches to influenza chemotherapy. [J]. Drugs, 1998,56 (4) : 537
  • 5[5]The MIST Study Group. Randomised trial of efficacy and safety inhaled zanamivir in treatment of influnza A and B virus infection. [J]. Lancet, 1998,352 : 1877
  • 6[6]Siagy CA. Treating influnza with zanamivir. [J]. Lancet, 1999,353:669
  • 7[7]Monto AS, Robinson DP, Herlocher ML, et al. Safety and efficacy of the neuraminidase inhibitor zanamivir in prevention of influenza among healthy adaults. [J]. JAMA, 1999,282 : 31
  • 8[8]Woodhead M, Lavanchy D. Neuraminidase inhibitors:progress in the management of influenza. [J]. IJCP,2000, 54(9) :604
  • 9[9]Kim CU, Lew W, Willams MA, et al. Influenza neuraminidase inhibitors prossessing a novel hydrophobic interaction in the enzyme active site :design ,synthesis ,and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. [J]. J Am Chem Soc,1997, 119(4):681
  • 10[10]Tai CY, Escarpe PA, Sidwell RW, et al. Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS4071. [J]. Antimicrob Agents Chemother, 1998,42 : 3234

共引文献26

同被引文献20

  • 1徐红,钱渊,许航,张家淮,朱汝南,王芳.甲3型流感病毒流行株金刚烷胺耐药性的初步研究[J].中华医学杂志,2006,86(14):996-998. 被引量：6
  • 2Dawood FS, Jain S, Finclli L, et al. Emergence of a novel swine- origin influenza A (HIN1) virus in humans[J]. N Engl J Med, 2009,360(25 ) : 2605-2615.
  • 3World health Organization. Pandemic (H1N 1 ) 2009 up date 90 [R/OL]. Geneva, WHO [2010-03-05]. Http:/www.who.int/csr/ don/2010-03-05/en/index.html.
  • 4Reid AH, Fanning TG, Janczewski TA, et al. Characterization of the 1918"Spanish" influenza virus matrix gene segment[J]. J Virol, 2002,76(21 ) : 10717-10723.
  • 5Belshe RB, Burk B, Newman F, et al. Resistance of influenza A virus to amantadine and fimantadine: results of one decade of surveillance [ J ]. J Infect Dis, 1989,159 (3) : 430-435.
  • 6Qi X, Li X, Rider P, et al. Molecular characterization of highly pathogenic HSN1 avian influenza A viruses isolated from raccoon dogs in China[J]. PLoS One, 2009, 4(3): e4682. DOI: 10. 1371/journal. pone. 0004682.
  • 7Gubareva LV. Molecular mechanisms of influenza virus resist- ance to neuraminidase inhibitors[J]. Virus Res, 2004, 103 (1- 2) : 199-203.
  • 8CDC. Oseltamivir-resistant 2009 pandemic influenza A(H1N1) virus infection in two summer campers receiving prophylaxis- North Carolina, 2009[-R~. Morb Mortal Wkly Rep, 2009, 58 (35) : 969-972.
  • 9Chen H, Cheung CL, Yuen KY, et al. Oseltamivir-resistant in- fluenza A pandemic(H1N1)2009 virus, Hong Kong, China[J]. Emerg Infect Dis, 2009, 15.. 1970-1972. DOI: 10. 3201 / eidlS12. 091057.
  • 10CDC. Oseltamivir-resistant novel influenza A (H1N1) virus in- fection in two immunosuppress -ed patients-Seattle, Washing- ton, 2009[R]. Morb Mortal Wkly Rep, 2009, 58(32): 893- 896.

引证文献2

二级引证文献3

解放军医学杂志
2010年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部